• linkedin
  • Increase Font
  • Sharebar

    DEA proposes listing three steroids under Schedule III

    Since three steroids have a high potential for drug abuse and trafficking, the Drug Enforcement Administration wants to classify them as Schedule III controlled substances.


    The Drug Enforcement Administration is proposing to classify three steroids as Schedule III controlled substances to avoid the potential for drug abuse and trafficking. The three steroids are: boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione. DEA said currently these steroids are not approved for medical use. However, there are some companies, primarily Internet- and China-based, that are selling them. This proposal, if approved, will bar the importation, exportation, and sale of these substances except for legitimate research or industrial uses. Those who wish to comment on this proposal should send them in by June 24.

    To see more Daily News articles, click here.

    To go to the Drug Topics homepage, click here.

    2018 Novel Drug Approvals: The First Five
    2018 Novel Drug Approvals: The First ...

    Signs point to a cooling on the FDA's fiery approval pace of 2017, but 2018 has already seen five novel drug approvals.

    Five Tips for Surviving a 12-Hour ...
    The Top 5 Pharmacist Movies of All Time
    Top 5 Problem Dietary Supplements